The FDA Drug Approval Process: Focus on Pediatric Labeling
MANY HEALTHCARE professionals are not familiar with the current Food and Drug Administration (FDA) drug approval process, especially with regard to the system's impact on pediatric patients. This column reviews the definition of pediatric labeling and its importance in the treatment of children, the history of drug regulation legislation, and the current drug approval process, proposes explanations for the deficit in pediatric labeling, and describes the steps that have been taken to correct this deficit.
Document Type: Research Article
Publication date: 01 April 2001
- Neonatal Network is no longer available to subscribers on Ingenta Connect. Please go to http://connect.springerpub.com/content/sgrnn to access your online subscription to Neonatal Network.
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content